IBDEI0PX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11562,1,3,0)
 ;;=3^Eye/Vision Exam After Failed Exam w/ Abnormal Findings 
 ;;^UTILITY(U,$J,358.3,11562,1,4,0)
 ;;=4^Z01.021
 ;;^UTILITY(U,$J,358.3,11562,2)
 ;;=^5158319
 ;;^UTILITY(U,$J,358.3,11563,0)
 ;;=Z01.020^^77^739^8
 ;;^UTILITY(U,$J,358.3,11563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11563,1,3,0)
 ;;=3^Eye/Vision Exam After Failed Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,11563,1,4,0)
 ;;=4^Z01.020
 ;;^UTILITY(U,$J,358.3,11563,2)
 ;;=^5158318
 ;;^UTILITY(U,$J,358.3,11564,0)
 ;;=Z82.1^^77^739^11
 ;;^UTILITY(U,$J,358.3,11564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11564,1,3,0)
 ;;=3^Family Hx Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,11564,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,11564,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,11565,0)
 ;;=Z83.518^^77^739^12
 ;;^UTILITY(U,$J,358.3,11565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11565,1,3,0)
 ;;=3^Family Hx Other Eye Disorder
 ;;^UTILITY(U,$J,358.3,11565,1,4,0)
 ;;=4^Z83.518
 ;;^UTILITY(U,$J,358.3,11565,2)
 ;;=^5063383
 ;;^UTILITY(U,$J,358.3,11566,0)
 ;;=Z83.511^^77^739^13
 ;;^UTILITY(U,$J,358.3,11566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11566,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,11566,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,11566,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,11567,0)
 ;;=H35.3211^^77^740^1
 ;;^UTILITY(U,$J,358.3,11567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11567,1,3,0)
 ;;=3^Exudative AMD,RIGHT eye,active CNV
 ;;^UTILITY(U,$J,358.3,11567,1,4,0)
 ;;=4^H35.3211
 ;;^UTILITY(U,$J,358.3,11567,2)
 ;;=^5138521
 ;;^UTILITY(U,$J,358.3,11568,0)
 ;;=H35.3221^^77^740^2
 ;;^UTILITY(U,$J,358.3,11568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11568,1,3,0)
 ;;=3^Exudative AMD,LEFT eye,active CNV 
 ;;^UTILITY(U,$J,358.3,11568,1,4,0)
 ;;=4^H35.3221
 ;;^UTILITY(U,$J,358.3,11568,2)
 ;;=^5138525
 ;;^UTILITY(U,$J,358.3,11569,0)
 ;;=H35.059^^77^740^3
 ;;^UTILITY(U,$J,358.3,11569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11569,1,3,0)
 ;;=3^Retinal CNV or NV,unspec          
 ;;^UTILITY(U,$J,358.3,11569,1,4,0)
 ;;=4^H35.059
 ;;^UTILITY(U,$J,358.3,11569,2)
 ;;=^5005601
 ;;^UTILITY(U,$J,358.3,11570,0)
 ;;=H35.82^^77^740^4
 ;;^UTILITY(U,$J,358.3,11570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11570,1,3,0)
 ;;=3^Retinal Ischemia,unspec           
 ;;^UTILITY(U,$J,358.3,11570,1,4,0)
 ;;=4^H35.82
 ;;^UTILITY(U,$J,358.3,11570,2)
 ;;=^5005716
 ;;^UTILITY(U,$J,358.3,11571,0)
 ;;=H35.81^^77^740^5
 ;;^UTILITY(U,$J,358.3,11571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11571,1,3,0)
 ;;=3^Retinal Edema,unspec              
 ;;^UTILITY(U,$J,358.3,11571,1,4,0)
 ;;=4^H35.81
 ;;^UTILITY(U,$J,358.3,11571,2)
 ;;=^5005715
 ;;^UTILITY(U,$J,358.3,11572,0)
 ;;=E11.3211^^77^740^6
 ;;^UTILITY(U,$J,358.3,11572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11572,1,3,0)
 ;;=3^DM Type 2 Mild NPDR w/ CME,RIGHT eye    
 ;;^UTILITY(U,$J,358.3,11572,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,11572,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,11573,0)
 ;;=E11.3212^^77^740^7
 ;;^UTILITY(U,$J,358.3,11573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11573,1,3,0)
 ;;=3^DM Type 2 Mild NPDR w/ CME,LEFT eye     
 ;;^UTILITY(U,$J,358.3,11573,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,11573,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,11574,0)
 ;;=E11.3311^^77^740^8
 ;;^UTILITY(U,$J,358.3,11574,1,0)
 ;;=^358.31IA^4^2
